 |
|
Linking Laboratory and Pharmacy
Opportunities for Reducing Errors and Improving Care
Gordon D. Schiff, MD;
David Klass, MD;
Josh Peterson, MD;
Gaurav Shah, MD;
David W. Bates, MD, MSc
Arch Intern Med. 2003;163:893-900.
A myriad of errors and lost improvement opportunities result from failure of clinical laboratory and pharmacy information systems to effectively communicate. Pharmacotherapy could benefit from enhanced laboratory-pharmacy linkage with respect to (1) drug choice (laboratory-based indications and contraindications), (2) drug dosing (renal or hepatic, blood level–guided adjustments), (3) laboratory monitoring (laboratory signals of toxicity, baseline and ongoing monitoring), (4) laboratory result interpretation (drug interfering with test), and (5) broader quality improvement (surveillance for unrecognized toxicity, monitoring clinician response delays). Linkages can be retrospective or real-time. Many organizations could benefit now by linking existing pharmacy and laboratory data. Greater improvement is possible through implementation of electronic order entry with real-time decision support incorporating linked laboratory and pharmacy data. While many guidelines, admonitions, and rules exist regarding drugs and the laboratory, substantial new knowledge and evidence in this area are needed. Focusing on these unmet needs and accompanying logistical challenges is a priority.
From the Department of Medicine, Cook County Hospital (Drs Schiff and Shah), Rush Medical College (Dr Schiff), Chicago, Ill; State of Illinois Department of Mental Health, University of Chicago Medical School (Dr Klass); Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tenn (Dr Peterson); and Division of General Internal Medicine, Brigham and Women's Hospital and Partners Healthcare Information Systems, Boston, Mass (Dr Bates). Dr Klass is now with VigiLanz Corporation, St Paul, Minn. Dr Bates has received honoraria for speaking from the Eclipsys Corporation, Boca Raton, Fla, and from Automated Healthcare; is a coinventor on patent No. 6029138 held by Brigham and Women's Hospital on the use of decision support software for medical management, licensed to the Medicalis Corporation, Waterloo, Ontario; holds a minority equity position in Medicalis Corporation; is a consultant and serves on the advisory board for McKesson MedManagement, Brooklyn Park, Minn; is on the clinical advisory boards for Zynx Inc, Beverly Hills, Calif, and SoCurious Inc, San Francisco, Calif; and is a consultant for Alaris, San Diego, Calif. Drs Schiff, Peterson, and Shah have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Compliance with Platelet Count Monitoring Recommendations and Management of Possible Heparin-Induced Thrombocytopenia in Hospitalized Patients Receiving Low-Molecular-Weight Heparin
ten Berg et al.
The Annals of Pharmacotherapy 2009;43:1405-1412.
ABSTRACT
| FULL TEXT
Promoting More Conservative Prescribing
Schiff and Galanter
JAMA 2009;301:865-867.
FULL TEXT
Impact of Non-interruptive Medication Laboratory Monitoring Alerts in Ambulatory Care
Lo et al.
J. Am. Med. Inform. Assoc. 2009;16:66-71.
ABSTRACT
| FULL TEXT
Can Surveillance Systems Identify and Avert Adverse Drug Events? A Prospective Evaluation of a Commercial Application
Jha et al.
J. Am. Med. Inform. Assoc. 2008;15:647-653.
ABSTRACT
| FULL TEXT
A Randomized Trial of Electronic Clinical Reminders to Improve Medication Laboratory Monitoring
Matheny et al.
J. Am. Med. Inform. Assoc. 2008;15:424-429.
ABSTRACT
| FULL TEXT
Laboratory Medicine: Challenges and Opportunities
Bossuyt et al.
Clin. Chem. 2007;53:1730-1733.
ABSTRACT
| FULL TEXT
Effects of an integrated clinical information system on medication safety in a multi-hospital setting
Mahoney et al.
Am J Health Syst Pharm 2007;64:1969-1977.
ABSTRACT
| FULL TEXT
A Systematic Review of the Performance Characteristics of Clinical Event Monitor Signals Used to Detect Adverse Drug Events in the Hospital Setting
Handler et al.
J. Am. Med. Inform. Assoc. 2007;14:451-458.
ABSTRACT
| FULL TEXT
Randomized Trial to Improve Prescribing Safety During Pregnancy
Raebel et al.
J. Am. Med. Inform. Assoc. 2007;14:440-450.
ABSTRACT
| FULL TEXT
Measuring Drug Burden: A Step Forward
Agostini
Arch Intern Med 2007;167:753-754.
FULL TEXT
Improved therapeutic monitoring with several interventions: a randomized trial.
Feldstein et al.
Arch Intern Med 2006;166:1848-1854.
ABSTRACT
| FULL TEXT
Drug Dosage Adjustments According to Renal Function at Hospital Discharge
van Dijk et al.
The Annals of Pharmacotherapy 2006;40:1254-1260.
ABSTRACT
| FULL TEXT
Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit
Thursky et al.
Int J Qual Health Care 2006;18:224-231.
ABSTRACT
| FULL TEXT
Overriding of Drug Safety Alerts in Computerized Physician Order Entry
van der Sijs et al.
J. Am. Med. Inform. Assoc. 2006;13:138-147.
ABSTRACT
| FULL TEXT
The Long Road to Patient Safety: A Status Report on Patient Safety Systems
Longo et al.
JAMA 2005;294:2858-2865.
ABSTRACT
| FULL TEXT
Comprehensive Analysis of a Medication Dosing Error Related to CPOE
Horsky et al.
J. Am. Med. Inform. Assoc. 2005;12:377-382.
ABSTRACT
| FULL TEXT
Missed Hypothyroidism Diagnosis Uncovered by Linking Laboratory and Pharmacy Data
Schiff et al.
Arch Intern Med 2005;165:574-577.
ABSTRACT
| FULL TEXT
Inappropriate Prescribing for Elderly Americans in a Large Outpatient Population
Curtis et al.
Arch Intern Med 2004;164:1621-1625.
ABSTRACT
| FULL TEXT
Adverse drug events and medication errors: detection and classification methods
Morimoto et al.
Qual Saf Health Care 2004;13:306-314.
ABSTRACT
| FULL TEXT
|
